Home » Topics » BioWorld

BioWorld
RSS

IMMUNEX BEGINS SARCOMA TREATMENT TRIALS

Oct. 18, 1991

CAMBRIDGE BIO RAISES $25.6 MILLION

Oct. 18, 1991

EPOGEN, NEUPOGEN SALES DRIVE AMGEN EARNINGS

Oct. 18, 1991

MYCOGEN FILES FOR OFFERING

Oct. 18, 1991

CELLPRO MARKETS FIRST PRODUCT

Oct. 18, 1991

DEPRENYL CRADA WITH ITRI

Oct. 18, 1991

FDA APPROVES PROSORBA COLUMN TRIALS

Oct. 18, 1991

TRIALS OF GROWTH FACTOR IN EYE SURGERY

Oct. 18, 1991

CIBA DIVISION ALLIANCE WITH INSITE

Oct. 17, 1991

SUNY/ENZO WIN ANTISENSE DISPUTE

Oct. 17, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...